Analysis of Outcomes and Standardized Protocol for Facial Harmonization with Fifth-Generation Plasma Gel Using CIROI Technology
DOI:
https://doi.org/10.70577/asce.v5i3.974Keywords:
facial harmonization; plasma gel; autologous plasma; CIROI technology; regenerative medicine; standardized protocolAbstract
The standardization of protocols in aesthetic regenerative medicine represents a fundamental challenge to ensure the reproducibility and safety of treatments with autologous biological products. This theoretical article critically analyzes the outcomes reported in the scientific literature and establishes a standardized protocol for facial harmonization with fifth-generation plasma gel assisted by CIROI technology. Through a systematic review of available evidence (2019-2025) and analysis of the biophysical foundations of plasma gel, a conceptual model is developed that integrates three interdependent components: the optimal biophysical parameters of plasma gel, the CIROI technological system as a process control device, and the clinical evaluation framework. The analysis demonstrates that the integration of standardization technologies allows for the reduction of interoperator variability by more than 80%, ensures complete process traceability, and achieves patient satisfaction rates exceeding 94%. The proposed protocol specifies critical technical parameters, including centrifugation times, applied G-forces, activation methods, and application techniques. It is concluded that the adoption of technology-assisted standardized protocols constitutes a methodological imperative for evidence-based aesthetic medicine, establishing the foundation for reproducible, safe, and scientifically valid clinical practice.
Downloads
References
American Society of Plastic Surgeons. (2020). Evidence-based clinical practice guidelines: Autologous fat grafting and platelet-rich plasma. Plastic and Reconstructive Surgery, 146(3), 381e-393e. https://doi.org/10.1097/PRS.0000000000007090
Bausset, O., Giraudo, L., Veran, J., Magalon, J., Coudreuse, J. M., Magalon, G., ... & Serratrice, N. (2021). Formulation and storage of platelet-rich plasma homemade product: A comparative study. BioResources and Bioprocessing, 8(1), 1-11. https://doi.org/10.1186/s40643-020-00357-z
CIROI BioTech. (2021). Manual del sistema CIROI-PlasmaManager® G5: Especificaciones técnicas y protocolo operativo (Versión 3.1). Documentación técnica interna.
Critical Appraisal Skills Programme. (2023). CASP checklists. https://casp-uk.net/casp-tools-checklists/
European Medicines Agency. (2022). Guideline on quality and safety of autologous platelet-rich plasma preparations. EMA/CHMP/BWP/536110/2021.
Fernández, A., Costa, M., & Silva, R. (2020). Standardization challenges in autologous biological therapies: A systematic review and meta-analysis. Aesthetic Surgery Journal, 40(5), NP278-NP290. https://doi.org/10.1093/asj/sjz333
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J., Gavaghan, D. J., & McQuay, H. J. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials, 17(1), 1-12. https://doi.org/10.1016/0197-2456(95)00134-4
Kim, S., Lee, H., Park, J., & Choi, Y. (2021). Comparative efficacy of fifth-generation plasma gel versus conventional platelet-rich plasma for facial rejuvenation: A randomized, split-face clinical trial. Journal of Cosmetic Dermatology, 20(8), 2552-2558. https://doi.org/10.1111/jocd.14245
López, J., González, M., & Ruiz, P. (2022). Impact of centrifugation parameters on platelet recovery and growth factor release in platelet-rich plasma preparations. Biotechnology and Bioengineering, 119(4), 1123-1135. https://doi.org/10.1002/bit.28032
Mautner, K., Malanga, G. A., Smith, J., Shiple, B., Ibrahim, V., & Sampson, S. (2019). A call for standardization in platelet-rich plasma preparation protocols and composition reporting: A systematic review of the clinical orthopaedic literature. Journal of Bone and Joint Surgery, 101(14), 1310-1318. https://doi.org/10.2106/JBJS.18.00937
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Systematic Reviews, 10(1), 89. https://doi.org/10.1186/s13643-021-01626-4
Rodríguez, P., & Lima, E. (2021). Fifth-generation platelet-rich plasma: Production parameters, quality control, and clinical applications in aesthetic medicine. Dermatologic Therapy, 34(3), e14948. https://doi.org/10.1111/dth.14948
Sánchez, M., García, O., Torres, V., & Martínez, J. (2022). Plasma gel in regenerative aesthetics: Physicochemical properties, preparation protocols, and clinical outcomes analysis. International Journal of Molecular Sciences, 23(14), 7891. https://doi.org/10.3390/ijms23147891
World Health Organization. (2023). Global standards for the production and clinical use of autologous biological products (WHO Technical Report Series, No. 1045). https://www.who.int/publications/i/item/9789240069733
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dr Bolívar Augusto Merino Montoya , Lcda Veronica Paola Jarrin Yerovi , Andrea Johanna Villena Condor , Dra Kimberling Del Carmen Jimenez Diaz , Maijuly Alejandra Gonzalez Mendez

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Eres libre de:
- Compartir : copiar y redistribuir el material en cualquier medio o formato
- Adaptar : remezclar, transformar y desarrollar el material
- El licenciante no puede revocar estas libertades siempre y cuando usted cumpla con los términos de la licencia.
En los siguientes términos:
- Atribución : Debe otorgar el crédito correspondiente , proporcionar un enlace a la licencia e indicar si se realizaron cambios . Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o a su uso.
- No comercial : no puede utilizar el material con fines comerciales .
- CompartirIgual — Si remezcla, transforma o construye sobre el material, debe distribuir sus contribuciones bajo la misma licencia que el original.
- Sin restricciones adicionales : no puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otros hacer algo que la licencia permite.














